1-9 of 9
Jakub Svoboda
Close
Sort by
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines

Clinical Trials & Observations
Guido Ghilardi, Luca Paruzzo, Jakub Svoboda, Elise A. Chong, Alexander A. Shestov, Linhui Chen, Ivan J. Cohen, Giulia Gabrielli, Sunita D. Nasta, Patrizia Porazzi, Daniel J. Landsburg, James N. Gerson, Jordan Carter, Stefan K. Barta, Rebecca Yelton, Raymone Pajarillo, Vrutti Patel, Griffin White, Hatcher J. Ballard, Elizabeth Weber, Ellen Napier, Emeline R. Chong, Joseph A. Fraietta, Alfred L. Garfall, David L. Porter, Michael C. Milone, Roderick O’Connor, Stephen J. Schuster, Marco Ruella
Journal: Blood Advances
Blood Adv (2024) 8 (3): 653–666.
https://doi.org/10.1182/bloodadvances.2023011492
Published: 2024
Includes: Supplemental data
Journal Articles

TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era

Daniel J. Landsburg, Jennifer JD Morrissette, Sunita D. Nasta, Stefan K. Barta, Stephen J. Schuster, Jakub Svoboda, Elise A. Chong, Adam Bagg
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7243–7253.
https://doi.org/10.1182/bloodadvances.2023011384
Published: 2023
Includes: Supplemental data
Journal Articles

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

Jackson T. Bowers, Jacob Anna, Steven M. Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A. Spinner, Shuning Li, Marcus R. Messmer, Joseph Nguyen, Emily C. Ayers, Charlotte B. Wagner, Boyu Hu, Mengyang Di, Scott F. Huntington, Fateeha Furqan, Nirav N. Shah, Christina Chen, Hatcher J. Ballard, Mitchell E. Hughes, Elise A. Chong, Sunita D. Nasta, Stefan K. Barta, Daniel J. Landsburg, Jakub Svoboda
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6630–6638.
https://doi.org/10.1182/bloodadvances.2023010622
Published: 2023
Includes: Supplemental data
Journal Articles

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma

Clinical Trials & Observations
Samuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, Paul Christos, Bijal Shah, Stephen J. Schuster, Sonali M. Smith, Jakub Svoboda, Richard R. Furman, John P. Leonard, Peter Martin, Jia Ruan
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6579–6588.
https://doi.org/10.1182/bloodadvances.2023010606
Published: 2023
Journal Articles

Adoptive T-cell therapy for Hodgkin lymphoma

Carrie Ho, Marco Ruella, Bruce L. Levine, Jakub Svoboda
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4291–4302.
https://doi.org/10.1182/bloodadvances.2021005304
Published: 2021
Journal Articles

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Clinical Trials & Observations
Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J. Voorhees, Natalie S. Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T. Hill, Eric Mou, Ranjana H. Advani, Jordan Carter, Kevin A. David, Hatcher J. Ballard, Jakub Svoboda, Michael C. Churnetski, Gabriela Magarelli, Tatyana A. Feldman, Jonathon B. Cohen, Andrew M. Evens, Craig A. Portell
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3623–3632.
https://doi.org/10.1182/bloodadvances.2021004645
Published: 2021
Includes: Supplemental data
Journal Articles

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Reid W. Merryman, Robert A. Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, Justin M. Darrah, Uttam Rao, Michael T. Byrne, David A. Bond, Kami J. Maddocks, Michael A. Spinner, Ranjana H. Advani, Hatcher J. Ballard, Jakub Svoboda, Anurag K. Singh, Joseph P. McGuirk, Dipenkumar Modi, Radhakrishnan Ramchandren, Jason Romancik, Jonathon B. Cohen, Matthew J. Frigault, Yi-Bin Chen, Anthony V. Serritella, Justine Kline, Stephen Ansell, Sunita Nathan, Maryam Rahimian, Robin M. Joyce, Mansi Shah, Kevin A. David, Steven Park, Anne W. Beaven, Alma Habib, Veronika Bachanova, Shazia Nakhoda, Nadia Khan, Ryan C. Lynch, Stephen D. Smith, Vincent T. Ho, Ann LaCasce, Philippe Armand, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1648–1659.
https://doi.org/10.1182/bloodadvances.2020003556
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy

Clinical Trials & Observations
Daniel J. Landsburg, Mitchell E. Hughes, Alexa Koike, David Bond, Kami J. Maddocks, Ling Guo, Allison M. Winter, Brian T. Hill, Sarah L. Ondrejka, Eric D. Hsi, Sunita D. Nasta, Jakub Svoboda, Stephen J. Schuster, Agata M. Bogusz
Journal: Blood Advances
Blood Adv (2019) 3 (2): 132–135.
https://doi.org/10.1182/bloodadvances.2018026401
Published: 2019